title: MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.
authors: a Department of Medicine , University of California Irvine , Orange , CA , USA.
authors: Wei
authors: W
authors: Yang
authors: b Division of Hematology-Oncology , University of California Irvine , Orange , CA , USA.
authors: Phu
authors: P
authors: Tran
authors: b Division of Hematology-Oncology , University of California Irvine , Orange , CA , USA.
authors: Ziad
authors: Z
authors: Khan
authors: c Department of Pathology and Laboratory Medicine , University of California Irvine , Orange , CA , USA.
authors: Sherif
authors: S
authors: Rezk
authors: b Division of Hematology-Oncology , University of California Irvine , Orange , CA , USA.
authors: Susan
authors: S
authors: O'Brien
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D015415:Biomarkers; D018450:Disease Progression; D015321:Gene Rearrangement; D011495:Histone-Lysine N-Methyltransferase / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D016130:Immunophenotyping; D015456:Leukemia, Biphenotypic, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics* / Q000378:metabolism; D010641:Phenotype; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D012008:Recurrence; D014178:Translocation, Genetic; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; C497422:KMT2A protein, human; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase